Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sepsis: definitions and diagnosis

W Karzai1, K Reinhart

  • 1Klinik für Anästhesiologie und Intensivtherapie, Klinikum der Friedrich-Schiller-Universität, Jena, Germany.

International Journal of Clinical Practice. Supplement
|October 31, 1998
PubMed
Summary

Current sepsis definitions are too broad for effective treatment. Researchers propose defining sepsis as an inflammatory response to infection with organ dysfunction, using biomarkers like cytokines and procalcitonin for better patient stratification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sepsis incidence in Germany and worldwide : Current knowledge and limitations of research using health claims data].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2021
Same author

COVID-19 reinforces the need to improve sepsis care resources in Africa.

Infection·2021
Same author

Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.

Intensive care medicine·2020
Same author

Correction to: Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.

Trials·2019
Same author

Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.

Trials·2019
Same author

Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany.

Intensive care medicine·2018

Area of Science:

  • * Critical Care Medicine
  • * Infectious Diseases
  • * Immunology

Background:

  • * Existing sepsis diagnostic criteria lack specificity, hindering targeted therapies and leading to disappointing clinical trial outcomes.
  • * The broadness of current definitions makes it difficult for clinicians to identify patients who would benefit from specific immunomodulatory treatments.
  • * Recent immunomodulatory trials have failed, suggesting a need for revised sepsis diagnostic criteria.

Purpose of the Study:

  • * To propose a refined definition of sepsis that enhances clinical and experimental relevance.
  • * To identify potential biomarkers for improved sepsis diagnosis and patient management.
  • * To facilitate the selection of patients for immunomodulatory therapies.

Main Methods:

Related Experiment Videos

  • * Review of existing sepsis definitions and their limitations in clinical practice and research.
  • * Analysis of the role of systemic inflammatory response markers in sepsis.
  • * Discussion of proposed diagnostic criteria incorporating organ dysfunction and inflammatory markers.

Main Results:

  • * Current sepsis definitions are inadequate for precise patient stratification and therapeutic guidance.
  • * Proposed definition: Sepsis as an inflammatory response to infection with signs of remote organ dysfunction.
  • * Biomarkers such as cytokines (e.g., TNF-alpha, IL-1, IL-6, IL-8) and procalcitonin show potential for improved diagnosis and monitoring.

Conclusions:

  • * A revised definition of sepsis is crucial for clinical and research advancement.
  • * Incorporating organ dysfunction and specific inflammatory markers can improve patient identification for targeted therapies.
  • * Biomarkers can aid in gauging inflammatory response extent and monitoring patient immune status.